1. Bluesky Feeds /
  2. Medsky Topics /
  3. NIH

A Medsky Topics feed composed of posts covering recent news related to the U.S. National Institutes of Health Powered by @medsky.social

Feed on Bluesky

Feeds Stats

  • 💙 Liked by 11 users
  • 📅 Updated 17 days ago
  • ⚙️ Provider graze.social

NIH Likes over time

Like count prediction
The feed NIH gains approximately 15 likes per month.

Feed Preview for NIH

STITCHES - the Best Papers in General Surgery
@stitches.today
about 1 hour ago
Robotic Colorectal Surgery Offers Shorter Hospital Stays by Vazquez VK, Albors LM, Liu H and Ang D in JSLS #Surgery #SurgSky #GeneralSurgery #MedSky 🪡 read our summary here 📖 read the article: pmc.ncbi.nlm.nih.gov/arti…
0
0
0
Jonathan Howard
@joho.bsky.social
about 9 hours ago
Our medical establishment rose to power based on things they “would have” done and things they“called for.” How are things going under their watch so far, now that they’ve had some time to prove their abilities and competence?
Jay Bhattacharya C @DrJBhattacharya
Follow
Imagine there hadn't been an @NIH-led
"devastating takedown" of the @gbdeclaration in Oct 2020. Imagine no media/social media suppression. We would have won the policy argument. Schools would have opened. We would have prioritized protection of the vulnerable. Instead, lockdowns.
1:44 AM • 12/9/22
1
4
13
Jonathan Howard
@joho.bsky.social
1 day ago
Our NIH director is trying to relive 2020 all the time on X. All of the grievances and insults from the good old days, from an account where countless people are blocked. Not much about the NIH.
2
4
24
Prof Gavin Yamey
@gavinyamey.bsky.social
1 day ago
Politico says Trump is “all in” on RFK Jr’s “plan to scrutinize the list of vaccines American children get” after RFK Jr’s extreme anti-vaxx ACIP votes to end newborn hep B vaccination And Jay Bhattacharya, on NEWSMAX, shows he is Trump’s biggest supporter & defender—MAGA & MAHA through & through😢
Trump asks RFK Jr to ‘fast track’ vaccine schedule review
NEWSMAX:
Dr Jay Bhattacharya: Trump is ‘pro-science’
1
11
16
American Society of Hematology
@ash.hematology.org
1 day ago
Spotted in the wild at #ASH25 👀 Explore the Toolkit for Clinical Trial Sponsors to build inclusive hematology trials, meet FDA and NIH expectations, and test your knowledge with an interactive game. ow.ly/ixtw50XENw3
0
0
3
Jonathan Howard
@joho.bsky.social
2 days ago
In December 2025, the head of the NIH is still complaining about blue checks on Twitter from 2021. H/t @mazer.us
2
5
26
Betty C. Jung
@bettycjung.bsky.social
2 days ago
RFK Jr. Fires NIH Whistleblower Dr. Jeanne Marrazzo, Who Objected to Trump Administration Policies on Vaccines people.com/rfk-jr-fires... This happened 10/4/2025. Another warning RFK Jr. was up to no good. He should be fired for what he's doing to Public Health.
RFK Jr. Fires NIH Whistleblower Dr. Jeanne Marrazzo, Who Objected to Trump Administration Policies on Vaccines

people.com

RFK Jr. Fires NIH Whistleblower Dr. Jeanne Marrazzo, Who Objected to Trump Administration Policies on Vaccines

Robert F. Kennedy Jr. has fired Dr. Jeanne Marrazzo, a top NIH scientist who filed a whistleblower complaint against the Trump administration in September. Marrazzo has claimed she was demoted and sil...

2
2
5
Timothy McBride
@mcbridetd.bsky.social
3 days ago
From NIH: Emergency Modifications to NIH Peer Review | Grants & Funding grants.nih.gov/news-events/...

grants.nih.gov

Emergency Modifications to NIH Peer Review | Grants & Funding

0
1
1
San Francisco Department of Public Health
@sfpublichealth.bsky.social
3 days ago
💙 It’s okay not to feel holiday joy. Dec–Jan can be especially difficult for those dealing with anxiety, PTSD, depression, or other mental health conditions. Tips from NIMH & NAMI: • Prioritize self-care • Avoid drugs/alcohol • Seek help when needed
0
0
0
Graze Social
@graze.social
23 days ago
Like what you're seeing? This feed runs on @graze.social, where the feeds you love come to life - pitch in below to support the team and keep the lights on!
Graze Social Tip Jar

buy.stripe.com

Graze Social Tip Jar

Donate to the Graze Social team and keep the feeds flowing!

2
26
74
ECOG-ACRIN Cancer Research Group
@eaonc.bsky.social
3 days ago
Attending #ASH25 this weekend? Don't miss the initial results from the myeloMATCH #PrecisionMedicine trial. More info on these exciting updates can be found here: dctd.cancer.gov/about/new….
MyeloMATCH Presentations at ASH 2025

dctd.cancer.gov

MyeloMATCH Presentations at ASH 2025

NCI's presentations on MyeloMATCH at the 2025 American Society of Hematology Annual Meeting

0
0
0
Prof Gavin Yamey
@gavinyamey.bsky.social
3 days ago
This is *literally* the eugenics-guided ethos of the RFK Jr/Great Barrington Declaration/anti-vaxx coalition Take a look, for example, at Jay Bhattacharya's new pandemic preparation 'plan,' which is: do nothing and hope that the fittest people survive (insidemedicine.substack.c…)

ah but you see sam, if the kids get liver cancer that just means they were meant to get it and Nature is doing its job

0
4
10
Pitt Department of Pediatrics
@pittpediatrics.bsky.social
3 days ago
Congrats to Drs. Mary Ellen Vajravelu and Maya Ragavan on their R01 grant from the NIDDK for thier ONWARD project looking at youth-onset type 2 diabetes! Read more about it here: www.pediatrics.pitt.edu/n….
0
0
1
UMass Chan Medical School
@umasschan.bsky.social
3 days ago
Researchers report that some journals are charging authors anywhere from $2,000 to more than $10,000 to make their work immediately accessible. Rachael Sirianni, PhD, comments in this Inside Higher Ed article: direc.to/oecx @docsirianni.bsky.social @insidehighered.com
The NIH Policy Holding Researchers “Hostage”

direc.to

The NIH Policy Holding Researchers “Hostage”

An effort to make NIH-funded research immediately accessible to the public has led to disruption and financial strain for scientists already navigating a precarious funding environment. It also spotli...

0
0
0
Joshua Weitz
@joshuasweitz.bsky.social
3 days ago
Cutting, delaying, and terminating science funding comes with costs to... discovery, projects, and people. One more example of impacts: to a NSF-funded Biology Integration Institute. It is well past time to restore expert-driven decision-making & stable budgets to NSF, NIH, CDC...

Yesterday, we sent this message to the @viralemergence.org team, bringing a (hopefully temporary) end to our project three years into what started as a decade of planned work. /1

Hi everyone,

I wanted to share some sad news about the future of the Verena program.

As you know, in September, NSF delayed our annual payment indefinitely, and asked us to keep spending closer and closer to zero until they could “justify” another payment. We began to run out of funds at some universities this month, and will be fully spent out by late spring, so the goal was to get paid in December. We’ve been working with our program officer to make this happen, but sadly, we’ve learned we’re not getting an increment again, and there’s no clarity on when or how much we will be paid in the remainder of the grant (through September 1, 2027).

Because of this, the Executive Committee has made the difficult decision to essentially shut the BII down until / unless something changes. What that means is an indefinite end to all programs (e.g., seminar), training activities (integration workshops, trainee corner), and evaluation. On research, what’s able to continue will have to be navigated by each investigator; our goal is to work together to push out all the impactful science we’ve spent three years collecting and analyzing data for, but we also know that priorities may shift around to keep people employed. 

If we’re lucky, Congress will pass a budget that lets us continue doing something like what we planned, and we’ll pick that back up when Zoe and Collin are back in April. Until then, Verena will continue to exist as a community where we can collaborate (and give and receive support!), and we’re working to find funding sources that can pick up from where the BII left off. 

On a personal note: it’s been the privilege of a lifetime to work with all of you, and an unbelievably lucky thing to get to run an NSF center in my 20s. I’ve loved this project, and I hope it’s made as much of a difference in your lives as it has in mine.

In case I don’t see you later: happy holidays, be well, and so long and thanks for all the viruses.

Best,
Colin
0
3
9
The Sick Times
@thesicktimes.org
3 days ago
🍼 Infants exposed to SARS-CoV-2 infection during pregnancy were more likely to have adverse neurodevelopmental diagnoses 💊 Metformin may help reduce risk of Long COVID 🧠 NIH is recruiting for a study on neurological symptoms of Long COVID This week's #LongCOVID research: bit.ly/4pncbXf
ID: A newborn is wrapped in a small blanket and wears a blue beanie after being delivered in a hospital. They rest on a blue pad. The text reads, “The Sick Times. Long COVID research updates. A study found that infants exposed to SARS-CoV-2 infection during pregnancy were more likely to have adverse neurodevelopmental diagnoses. Another study has found that the common diabetes drug metformin may help reduce the risk of Long COVID. NIH is recruiting for a study to understand if people with neurological symptoms of Long COVID have inactive remnants of SARS-CoV-2 in their bodies.”
A large retrospective cohort study of over 18,000 live births found that infants exposed to SARS-CoV-2 infection during pregnancy were more likely to have adverse neurodevelopmental diagnoses by the time they were three years old. Children included in the study, published in Obstetrics and Gynecology, were born between March 2020 and May 2021. This pattern, which included higher rates of speech, language, and motor function disorders, was most pronounced when infection occurred in the third trimester and in male children. “COVID is a real problem that poses risk to the mom in pregnancy and to the child,” one of the authors told ProPublica.
Another study has found that the common diabetes drug metformin may help reduce the risk of Long COVID. Shared as a preprint, the electronic health records study found a 53% lower risk of developing Long COVID when the drug was prescribed within six days of SARS-C0V-2 infection. The study included the health records of 496 people (248 in the metformin group. The authors concluded that the result of this study is consistent with randomized controlled trials and observational analyses on the drug for cutting Long COVID risk, and that it could be used to help guide treatment guidelines. Read more about metformin and Long COVID in our recent feature.
The National Institutes of Health (NIH) is recruiting for a small observational study to understand if people with neurological symptoms of Long COVID have inactive remnants of  SARS-CoV-2 in their bodies. The study is recruiting 12 people, including those with Long COVID neurological symptoms and those who have “recovered” from infection. Researchers will take tissue samples from multiple parts of the body, including the digestive tract, lungs, colon, muscle, and skin. Participants will also undergo a lumbar puncture. The study is based in Bethesda, Maryland. Study contact: Angelique Gavin, angelique.gavin@nih.gov.
2
10
28
CHOP Pediatric Emergency Medicine
@pematchop.bsky.social
3 days ago
🕷️ CHOP is in a Lyme-endemic area, and this time of year we see more early and late disseminated Lyme. In this study—with contributions from Dr. Fran Balamuth—the Pedi Lyme Net team examined how children with peripheral facial palsy are treated. pubmed.ncbi.nlm.nih....
1
0
2